Gamma-aminobutyric acid type A receptor alpha-2 beta-gamma-2 benzodiazepine site (GABA-A receptor alpha-2 beta-gamma-2 BZD site) (GABA-A receptor alpha-2 beta-gamma-2 BZD site)

The Gamma-aminobutyric acid type A (GABA-A) receptor alpha-2 beta-gamma-2 benzodiazepine site is a specific allosteric binding pocket located at the interface of the alpha-2 and gamma-2 subunits within the pentameric receptor complex (Rudolph & Knoflach, 2011, Nature Reviews Drug Discovery). As a ligand-gated chloride channel, the GABA-A receptor mediates the majority of fast inhibitory neurotransmission in the central nervous system (Sigel & Steinmann, 2012, Pharmacological Reviews). When benzodiazepines or related ligands bind to this site, they act as positive allosteric modulators, enhancing the receptor's affinity for GABA and increasing the frequency of channel opening (StatPearls, 2023). This specific alpha-2-containing subtype is primarily localized in the limbic system and is critically involved in mediating the anxiolytic and muscle-relaxant effects of benzodiazepines, distinct from the sedative effects mediated by alpha-1-containing receptors (Mohler, 2012, Advances in Pharmacology). Consequently, the alpha-2 beta-gamma-2 site is a major therapeutic target for developing "non-sedating" anxiolytics. Dysregulation of this receptor system is implicated in various neuropsychiatric conditions, including generalized anxiety disorder, panic disorder, and certain forms of epilepsy (Engin et al., 2012, Trends in Pharmacological Sciences). Selective targeting of the alpha-2 subunit remains a significant goal in neuropharmacology to minimize side effects like ataxia and sedation associated with traditional non-selective benzodiazepines (Atack, 2011, Current Topics in Behavioral Neurosciences).

Other names

Alpha-2 subunit-containing GABA-A receptorGABRA2-containing GABA-A receptorBenzodiazepine receptor alpha-2 subtypeGABA(A) receptor subunit alpha-2/beta/gamma-2 complex

Positive allosteric modulation of the GABA-A receptor, increasing the frequency of chloride channel opening in the presence of GABA (Sigel & Steinmann, 2012, Pharmacological Reviews).